4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-24-028647
EVP R&D, Chief Medical Officer sold 14,349 shares at $30.77 ($441,550)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2024-12-04 | Sale 10b5-1 | −14,349 | $30.77 | $441,550 | 68,951 | D |
| Open-market sales · 14,349 sh · avg $30.77 · $441,550 | |||||||
Loading xslF345X05/form4.xml…